• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK UNKNOWN (SURPASS STREAMLINE); INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK UNKNOWN (SURPASS STREAMLINE); INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Catalog Number UNK_NEU
Device Problems Break (1069); Activation Failure (3270)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/25/2019
Event Type  malfunction  
Manufacturer Narrative
Subject device is not available.
 
Event Description
It was reported that the patient underwent flow diverter( subject device) placement in the internal carotid artery (ica) left distal (close from t bifurcation).After first deployment, position was not optimal at the distal part, re-sheathing and redeployment was need several time with an active pushing between distal portion and median portion at the bride aneurysm neck level.After a good distal position, the surpass-evolve could not open at the median level.The anatomy was very severely tortuous.The physicians retrieve the stent system and observed that the stent was constrained, did not open at the median level, and some stent wires were broken.Similar flow diverters were used to complete the procedure.There was a 2 hours surgical delay due to the anatomy that does not allow to place a flow diverter ideally.There were no clinical consequences to the patient.
 
Manufacturer Narrative
The neurovascular stryker surpass evolve device is not currently not approved or commercially sold in the usa.The event for the surpass evolve device was filed to fda as a similar product to stryker device surpass streamline device that is commercially available in the us (b)(4) see section 4.11.3 guidance for industry and food and drug administration staff, (b)(6) 2016.
 
Event Description
It was reported that the patient underwent flow diverter(subject device) placement in the internal carotid artery (ica) left distal (close from t bifurcation).After first deployment, position was not optimal at the distal part, re-sheathing and redeployment was need several time with an active pushing between distal portion and median portion at the bride aneurysm neck level.After a good distal position, the surpass-evolve could not open at the median level.The anatomy was very severely tortuous.The physicians retrieve the stent system and observed that the stent was constrained, did not open at the median level, and some stent wires were broken.Similar flow diverters were used to complete the procedure.There was a 2 hours surgical delay due to the anatomy that does not allow to place a flow diverter ideally.There were no clinical consequences to the patient.
 
Manufacturer Narrative
The device history record confirms that the device met all material, assembly and performance specifications.Only the stent was returned.Visual inspection was performed on the returned device and it was observed that the flow diverter stent was deformed.Functional test could not be performed as only the stent was returned.The reported stent break was not confirmed; however the event was confirmed based on the damage noted to the device.As per the additional information, the patient¿s anatomy was severely tortuous.It is probable that the severe tortuosity of the patient¿s anatomy caused the stent to become damaged during the difficult advancement through the microcatheter and causing the subsequent failure to open the stent.An assignable cause of procedural factors will be assigned to the issues of difficulty engaging target vessel and failure to open.An assignable cause of not confirmed will be assigned to the reported stent break.
 
Event Description
It was reported that the patient underwent flow diverter(subject device) placement in the internal carotid artery (ica) left distal (close from t bifurcation).After first deployment, position was not optimal at the distal part, re-sheathing and redeployment was need several time with an active pushing between distal portion and median portion at the bride aneurysm neck level.After a good distal position, the surpass-evolve could not open at the median level.The anatomy was very severely tortuous.The physicians retrieve the stent system and observed that the stent was constrained, did not open at the median level, and some stent wires were broken.Similar flow diverters were used to complete the procedure.There was a 2 hours surgical delay due to the anatomy that does not allow to place a flow diverter ideally.There were no clinical consequences to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN (SURPASS STREAMLINE)
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
MDR Report Key8862607
MDR Text Key158869705
Report Number3008881809-2019-00228
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
PMA/PMN Number
P170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 12/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date05/08/2020
Device Catalogue NumberUNK_NEU
Device Lot Number21443550
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/06/2019
Initial Date Manufacturer Received 07/26/2019
Initial Date FDA Received08/05/2019
Supplement Dates Manufacturer Received09/24/2019
11/25/2019
Supplement Dates FDA Received09/25/2019
12/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
XT-27 MICROCATHETER (STRYKER)
Patient Age73 YR
-
-